USFDA APPLICATION NUMBER - 20164 / DOSAGE - INJECTABLE;SUBCUTANEOUS - 90MG/0.6ML (150MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Active Ingredient/Active Moiety | ||
Ingredient Name | Basis of Strength | Strength |
---|---|---|
enoxaparin sodium(UNII: 8NZ41MIK1O) (enoxaparin - UNII:E47C0NF7LV) | enoxaparin sodium | 150mg in 1 | 120mg in 0.8 | 300mg in 3 | 100mg in 1 | 80mg in 0.8 | 60mg in 0.6 | 40mg in 0.4 | 30mg in 0.3 |
Inactive Ingredients
Ingredient Name | Fresenius Kabi USA, LLC | sanofi-aventis U.S. LLC | Cardinal Health |
---|---|---|---|
BENZYL ALCOHOL(LKG8494WBH) | |||
water(059QF0KO0R) |
LOOKING FOR A SUPPLIER?